Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.4K Sell
19,175
-15,000
-44% -$13.5K ﹤0.01% 2112
2026
Q1
$51.6K Hold
34,175
﹤0.01% 2092
2025
Q4
$73.5K Buy
34,175
+3,603
+12% +$12.3K ﹤0.01% 983
2025
Q3
$147K Buy
30,572
+3,506
+13% +$19.1K ﹤0.01% 1764
2025
Q2
$150K Buy
27,066
+2,058
+8% +$16.3K ﹤0.01% 1679
2025
Q1
$307K Buy
25,008
+1,790
+8% +$27.3K ﹤0.01% 1399
2024
Q4
$311K Buy
23,218
+1,170
+5% +$13.3K ﹤0.01% 1366
2024
Q3
$207K Buy
22,048
+1,072
+5% +$10.9K ﹤0.01% 1323
2024
Q2
$204K Buy
20,976
+1,440
+7% +$14.2K ﹤0.01% 1297
2024
Q1
$205K Buy
19,536
+1,400
+8% +$17.3K ﹤0.01% 1299
2023
Q4
$242K Buy
18,136
+1,536
+9% +$21K 0.01% 1164
2023
Q3
$241K Buy
16,600
+1,264
+8% +$21.8K 0.01% 1107
2023
Q2
$302K Buy
+15,336
New +$241K 0.01% 961

Other funds holding GOCO

Empowered Funds's GOCO Position: Q2 2026 in Review

Empowered Funds reduced its GoHealth (GOCO) stake by 44% in Q2 2026, selling an estimated $13.5K and leaving 19,175 shares worth $7.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Empowered Funds first reported a position in GOCO in Q2 2023 and has held it in 13 quarters since. The position peaked at $311K in Q4 2024. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Empowered Funds held 19,175 shares of GoHealth worth $7.4K as of Q2 2026.
  • Empowered Funds sold 15,000 GoHealth shares in Q2 2026, an estimated $13.5K.
  • GoHealth made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #2112 holding.
  • Empowered Funds first reported a position in GoHealth in Q2 2023 and has held it in 13 quarters since.
  • Empowered Funds's GoHealth position peaked at $311K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.